Jane Goddard

1.9k total citations
33 papers, 1.4k citations indexed

About

Jane Goddard is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Nephrology. According to data from OpenAlex, Jane Goddard has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 17 papers in Physiology and 7 papers in Nephrology. Recurrent topics in Jane Goddard's work include Nitric Oxide and Endothelin Effects (17 papers), Blood Pressure and Hypertension Studies (16 papers) and Cardiovascular Health and Disease Prevention (9 papers). Jane Goddard is often cited by papers focused on Nitric Oxide and Endothelin Effects (17 papers), Blood Pressure and Hypertension Studies (16 papers) and Cardiovascular Health and Disease Prevention (9 papers). Jane Goddard collaborates with scholars based in United Kingdom, United States and Germany. Jane Goddard's co-authors include Neeraj Dhaun, David J. Webb, Neil R. Johnston, David J. Webb, Vanessa Melville, I. MacIntyre, A. J. Rankin, Pajaree Lilitkarntakul, Allan D. Cumming and David M. Pollock and has published in prestigious journals such as Circulation, Diabetes Care and Kidney International.

In The Last Decade

Jane Goddard

32 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Goddard United Kingdom 18 789 584 401 283 168 33 1.4k
Michiaki Usui Japan 11 706 0.9× 749 1.3× 212 0.5× 150 0.5× 155 0.9× 16 1.5k
Ulrike Raff Germany 20 431 0.5× 240 0.4× 205 0.5× 171 0.6× 181 1.1× 46 1.2k
Frank Benedetto Italy 12 767 1.0× 502 0.9× 396 1.0× 170 0.6× 87 0.5× 31 1.3k
Robert Wever Netherlands 11 685 0.9× 1.0k 1.7× 144 0.4× 178 0.6× 283 1.7× 14 2.0k
Masahito Imanishi Japan 24 487 0.6× 212 0.4× 328 0.8× 219 0.8× 258 1.5× 73 1.4k
Yoichiro Otaki Japan 23 665 0.8× 311 0.5× 268 0.7× 231 0.8× 311 1.9× 93 1.7k
H A Koomans Netherlands 24 811 1.0× 703 1.2× 447 1.1× 525 1.9× 457 2.7× 60 2.3k
Giulia Dell’Omo Italy 18 722 0.9× 134 0.2× 234 0.6× 173 0.6× 137 0.8× 47 1.3k
Sharon Anderson United States 21 519 0.7× 183 0.3× 662 1.7× 165 0.6× 362 2.2× 36 1.6k
Ah Siew Sim Australia 16 673 0.9× 715 1.2× 90 0.2× 120 0.4× 310 1.8× 17 1.7k

Countries citing papers authored by Jane Goddard

Since Specialization
Citations

This map shows the geographic impact of Jane Goddard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Goddard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Goddard more than expected).

Fields of papers citing papers by Jane Goddard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Goddard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Goddard. The network helps show where Jane Goddard may publish in the future.

Co-authorship network of co-authors of Jane Goddard

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Goddard. A scholar is included among the top collaborators of Jane Goddard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Goddard. Jane Goddard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Betz, Boris, Sara Jenks, Andrew D. Cronshaw, et al.. (2016). Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes. Kidney International. 89(5). 1125–1135. 62 indexed citations
2.
Reis, Ana, Alisa Rudnitskaya, Pajaree Chariyavilaskul, et al.. (2014). Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease. Journal of Lipid Research. 56(2). 413–422. 71 indexed citations
3.
Yüzügülen, Jale, Pajaree Lilitkarntakul, Elizabeth G. Wood, et al.. (2013). Evaluation of urinary and plasma endothelin-like domain peptide (ELDP) in chronic kidney disease. Life Sciences. 93(25-26). e14–e14. 1 indexed citations
4.
Dhaun, Neeraj, Vanessa Melville, Scott Blackwell, et al.. (2012). Endothelin-A Receptor Antagonism Modifies Cardiovascular Risk Factors in CKD. Journal of the American Society of Nephrology. 24(1). 31–36. 28 indexed citations
5.
Dhaun, Neeraj, et al.. (2012). What is the best method of proteinuria measurement in clinical trials of endothelin receptor antagonists?. Life Sciences. 91(13-14). 733–738. 5 indexed citations
6.
Sandilands, Euan A., Sharon Cameron, Jane Crowe, et al.. (2012). Mechanisms for an effect of acetylcysteine on renal function after exposure to radio-graphic contrast material: study protocol. PubMed. 12(1). 3–3. 14 indexed citations
7.
Dhaun, Neeraj, Jane Goddard, & David J. Webb. (2011). Endothelin Antagonism in Patients with Nondiabetic Chronic Kidney Disease. Contributions to nephrology. 172. 243–254. 9 indexed citations
8.
Lilitkarntakul, Pajaree, Neeraj Dhaun, Vanessa Melville, et al.. (2011). Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity. Atherosclerosis. 216(1). 217–225. 56 indexed citations
9.
MacIntyre, I., Neeraj Dhaun, Pajaree Lilitkarntakul, et al.. (2010). Greater Functional ET B Receptor Antagonism With Bosentan Than Sitaxsentan in Healthy Men. Hypertension. 55(6). 1406–1411. 12 indexed citations
10.
Dhaun, Neeraj, I. MacIntyre, Vanessa Melville, et al.. (2009). Blood Pressure–Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease. Hypertension. 54(1). 113–119. 101 indexed citations
11.
Dhaun, Neeraj, Pajaree Lilitkarntakul, I. MacIntyre, et al.. (2009). Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis. American Journal of Physiology-Renal Physiology. 296(6). F1477–F1483. 61 indexed citations
12.
Bennet, Simon, et al.. (2009). Acute renal dysfunction following hip fracture. Injury. 41(4). 335–338. 76 indexed citations
13.
Goddard, Jane, et al.. (2009). The Iron Age : introduction, stratification and architecture. Medical Entomology and Zoology.
14.
MacIntyre, I., Neeraj Dhaun, Jane Goddard, & David J. Webb. (2008). Sitaxsentan sodium for pulmonary hypertension. Drugs of today. 44(8). 585–585. 5 indexed citations
15.
Dhaun, Neeraj, Vanessa Melville, William G. Kramer, et al.. (2007). The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairment. British Journal of Clinical Pharmacology. 64(6). 733–737. 15 indexed citations
16.
Dhaun, Neeraj, et al.. (2006). The Endothelin System and Its Antagonism in Chronic Kidney Disease. Journal of the American Society of Nephrology. 17(4). 943–955. 184 indexed citations
17.
Goddard, Jane, et al.. (2004). Endothelin A Receptor Antagonism and Angiotensin-Converting Enzyme Inhibition Are Synergistic via an Endothelin B Receptor–Mediated and Nitric Oxide–Dependent Mechanism. Journal of the American Society of Nephrology. 15(10). 2601–2610. 46 indexed citations
18.
Spratt, James, Jane Goddard, Neil R. Patel, et al.. (2001). Systemic ETA receptor antagonism with BQ‐123 blocks ET‐1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. British Journal of Pharmacology. 134(3). 648–654. 75 indexed citations
19.
Goddard, Jane & David J. Webb. (2000). Plasma Endothelin Concentrations in Hypertension. Journal of Cardiovascular Pharmacology. 35(4 Suppl 2). S25–S31. 24 indexed citations
20.
Goddard, Jane & David J. Webb. (1999). Endothelin Receptor Antagonists. Drugs in R&D. 2(1). 1–12. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michiaki Usui Breakdown of academic impact, for papers by Ulrike Raff Breakdown of academic impact, for papers by Frank Benedetto Breakdown of academic impact, for papers by Robert Wever Breakdown of academic impact, for papers by Masahito Imanishi Breakdown of academic impact, for papers by Yoichiro Otaki Breakdown of academic impact, for papers by H A Koomans Breakdown of academic impact, for papers by Giulia Dell’Omo Breakdown of academic impact, for papers by Sharon Anderson Breakdown of academic impact, for papers by Ah Siew Sim
Rankless by CCL
2026